Insider Trading & Ownership of Christopher Grant Doughty

Location
Waltham, MA
Summary
The estimated net worth of Christopher Grant Doughty is at least $937,885 dollars as of 17 Dec 2025. Christopher Grant Doughty is the Chief Business Officer of CRESCENT BIOPHARMA, INC. and owns shares of CRESCENT BIOPHARMA, INC. (CBIO) stock worth about $937.9K.
Signature
/s/ Barbara Bispham, as attorney-in-fact for Christopher Doughty
All Insider Reports
All Insider Reports

Follow Filing Activity

Follow Christopher Grant Doughty and return when a new Insider Trading filing changes the record on this page.

This uses the existing product follow flow to surface future filing-backed changes without guessing what they mean.

Quick Takeaways

  • Christopher Grant Doughty has 1 issuer position tracked on this page.
  • Estimated disclosed ownership value: $937,885.
  • Recent insider filing activity is available below.

What Changed

  • Largest disclosed position: CRESCENT BIOPHARMA, INC. ($937,885).
  • Past-year value change for that position: .

Why This Matters

  • This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
  • You can cross-check role, issuer, and filing chronology directly against the SEC source.

Source Evidence

Filed on Form 4

Insider ownership context is sourced from SEC Forms 3, 4, and 5.

See Original Filing

Ownership of Christopher Grant Doughty

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
CBIO CRESCENT BIOPHARMA, INC. Chief Business Officer $937,885 15 Dec 2025

Insider Transactions Reported by Christopher Grant Doughty:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .